Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone

SIMPLE SUMMARY: Breast cancer (BCa) is a devastating disease, which has a high prevalence and mortality in women. BCa metastasis is a major cause of mortality, and bone metastasis accounts for the majority of BCa-associated deaths. The luminal B subtype of BCa is immunogenically low and has the high...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehdi, Ali, Attias, Mikhael, Arakelian, Ani, Piccirillo, Ciriaco A., Szyf, Moshe, Rabbani, Shafaat A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818024/
https://www.ncbi.nlm.nih.gov/pubmed/36612044
http://dx.doi.org/10.3390/cancers15010048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818024/
https://www.ncbi.nlm.nih.gov/pubmed/36612044
http://dx.doi.org/10.3390/cancers15010048

Ejemplares similares